Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by MyKnighton May 31, 2022 11:42am

222 Views

Post# 34720214

Complain at the BC SEC

Not sure how this is done, but from this site we can make complaint about the Fraud of Kalitera/Claritas ...
I will look at it this week and make a complaint.

I encourage everybody to make a complaint against does criminal

https://www.bcsc.bc.ca/about/contact-us

It's time we expose does Criminal, they had it way to easy in the last 5 years...

I believe that they are the one shorting this stock after every split it would be nice if we could investigate this....

I'm open to any suggestion.....

Good luck to everybody.